First AI-Generated Drug Enters Human Clinical Trials, Targeting Patients With Chronic Lung Diseases

Insilico Medicines CEO Alex Zhavoronkov (left) said the drug would undergo the same tests to ascertain its efficacy and safety.

Technician By Melissa Rudy, Fox News June 29, 2023 | 1:17 The first AI-generated drug has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently called INS018_055, is being tested for the treatment of idiopathic pulmonary fibrosis (IPF), a rare and progressive type … Read more

No SSN, no problem, says Maza, a fintech startup targeting undocumented immigrants

No SSN, no problem, says Maza, a fintech startup targeting undocumented immigrants

Image credits: John Moore/Getty Images Want more fintech news in your inbox? Registration Here. While there are a multitude of fintech companies offering digital banking services to a variety of demographics, there has been one segment of the population that has historically been underserved even more than others: the undocumented immigrant. Because undocumented immigrants lack … Read more